Interleukin-1β-31T/C promoter polymorphism and chronic obstructive pulmonary disease risk: A meta-analysis

Archives of Medical Science

Volumn 10, Issue 3, 2014, Pages 434-438

  Xiao, Min ^a,b   Guo, Lingli ^a,b   Wang, Tao ^a,b   Zhu, Tao ^a,b   Jia, Liuqun ^a,b   Chen, Lei ^a,b   Wen, Funqiang ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Interleukin 1 ; Polymorphism

Indexed keywords

INTERLEUKIN 1BETA;

ASIAN; CASE CONTROL STUDY; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA BASE; EFFECT SIZE; ETHNICITY; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MEDLINE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PUBLICATION; PUBLISHING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SYSTEMATIC REVIEW;

EID: 84903602580     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.43737     Document Type: Review

References (12)

1. Global Strategy for Diagnosis, Management, and Prevention of COPD (Updated 2013).
2. Ezzeldin N, Shalaby A, Saad-Hussein A, et al. Association of TNF-alpha -308 G/A, SP-B 1580 C/T, IL-13 -1055 C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population. Arch Med Sci 2012; 8: 286-95.
3. Kurowski M, Majkowska-Wojciechowska B, Wardzyńska A, Kowalski ML. Associations of allergic sensitization and clinical phenotypes with innate immune response genes polymorphisms are modified by house dust mite allergen exposure. Arch Med Sci 2011; 7: 1029-36.
4. Antczak A, Ciebiada M, Pietras T, Piotrowski WJ, Kurmanowska Z, Górski P. Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease. Arch Med Sci 2012; 8: 277-85.
5. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31: 1334-56.
6. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Metaanalyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years'research. Am J Respir Crit Care Med 2009; 180: 618-31.
7. Asada M, Yamaya M, Ebihara S, et al. Interleukin-1beta gene polymorphisms associated with COPD. Chest 2005; 128: 1072-3.
8. Hegab AE, Sakamoto T, Saitoh W, et al. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2005; 329: 1246-52.
9. Lee JM, Kang YR, Park SH, et al. Polymorphisms in interleukin- 1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study. Respir Med 2008; 102: 1311-20.
10. Liu Y, Liu X, Li H, Wang L. Relationship between polymorphism of IL-1beta gene and chronic obstructive pulmonary disease in Han population. Zhong Guo Man Xing Bing Yu Fang Yu Kong Zhi 2012; 20: 128-31.
11. Hsieh MH, Chong IW, Hwang JJ, et al. Lack of associations between several polymorphisms in cytokine genes and the risk of chronic obstructivepulmonary diseases in Taiwan. Kaohsiung J Med Sci 2008; 24: 126-37.
12. Chen L, Shen Y, Liu L, Li X, Wang T, Wen F. Interleukin-13 -1112 C/T promoter polymorphism confers risk for COPD: a meta-analysis. PloS One 2013; 8: e68222.